Robert N. Verratti

Operating Partner

116 past transactions

WebVision

Series B in 2000
Webvisions provided shared hosting, dedicated server and co-location services to small and midsized businesses throughout Asia.

Ventaira Pharmaceuticals

Series B in 2003
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary electrohydrodynamic (EHD) aerosolization and formulation technologies.

Sopherion Therapeutics

Venture Round in 2008
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company headquartered in Princeton, New Jersey with offices in Cheshire, Connecticut, Estero, Florida and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada. Sopherion’s current business focus is the execution of a Phase III, global, randomized, registration trial for first line therapy of invasive, metastatic breast cancer and the development and commercialization of Sopherion’s lead agent, Myocet™. Myocet is being investigated in an FDA agreed upon registration trial in combination with two other drugs, Herceptin® (Trastuzumab) and Taxol (Paclitaxel) vs. Herceptin® and Taxol alone, the current standard of care for first line HER-2-overexpressing metastatic breast cancer. Myocet™, a liposome-encapsulated doxorubicin with reduced cardiotoxicity, is a nanotechnology product that localizes into tumor vasculature and in contrast to parental doxorubicin avoids homing to the heart. This 363 patient global trial in twelve countries has as of 03/06/09 been fully recruited. Unblinding is anticipated by the summer of 2010 with NDA submission for full approval following within 6 months. Myocet® is already a registered drug in Canada, where Sopherion has commercial rights and in Europe where Cephalon has commercial rights for use in first line metastatic breast cancer in combination with cyclophosphamide.; Their Phase III trial is based on a Phase II trial, supported by Roche, which gave a 96% response rate and two and a half year median progression free survival for patients with metastatic breast cancer.

WebLogic

Venture Round in 1998
Provider of enterprise Java applications servers. The company provides application servers & transaction systems. It supplies Java application servers and Java-to-database integration services.

Matrix.Net

Series A in 2001
Incorporated in 1990, MIDS is a pioneer of electronic commerce. MIDS started Matrix IQ the first for-pay non-academic periodical distributed over the Internet drew the first maps of the Internet as a whole, conducted the first demographic survey of the Internet, MIDS Internet Average and first monitored the Internet as a whole. MIDS is known as the granddaddy of Internet monitoring service providers. Since 1993 MIDS has been collecting a continuous stream of data in Their Internet Weather Report MIDS Internet Weather Report. Since 1995, MIDS has been displaying IWR data on the web as animated GIF and Java maps of current conditions in the Internet. MIDS makes geographical maps of Internet hosts, hosts per capita, latencies, links, and other aspects of the Internet available.

IPnetwork

Series A in 1999
IPnetwork provides foreign advertising solutions via TV, radio, and internet delivery platforms.

Ascentive, LLC

Venture Round in 2000
We are an eclectic and energetic group of software developers, designers, marketers, media mavens, sales superstars and customer service professionals who work together to create innovative software products. Ascentiveâ€:tm:s mission statement is to develop easy-to-use software for consumers and businesses for solving everyday PC problems, backed by top-notch customer support and service. With a dozen products, Ascentive is a market leader in corporate and consumer software and has received accolades from media organizations like The Wall Street Journal, Newsweek, Forbes, Tech TV and NBC. Ascentive products and services are used by hundreds of thousands of people and businesses, with registered customers in 55 countries.
CICLON Semiconductor Device Corporation (pronounced see-clone) is a leader in the design, development, and sale of high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions for high-performance information technology applications. The company was founded in 2004 and is based in Bethlehem, Pennsylvania. As of February 11, 2009, CICLON Semiconductor Device Corp. operates as a subsidiary of Texas Instruments Inc.

Powered

Series A in 2000
Powered is a social marketing consultancy that helps companies become more engaged in an increasingly digital, connected and social world. Utilizing a proven set of effective practices and technologies, Powered helps companies navigate the entire social marketing spectrum, providing social marketing: strategy, planning, program development and execution, program management, content marketing, blogger outreach, influencer activation, advocacy programs, branded communities, and branded events.

Sopherion Therapeutics

Series A in 2003
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company headquartered in Princeton, New Jersey with offices in Cheshire, Connecticut, Estero, Florida and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada. Sopherion’s current business focus is the execution of a Phase III, global, randomized, registration trial for first line therapy of invasive, metastatic breast cancer and the development and commercialization of Sopherion’s lead agent, Myocet™. Myocet is being investigated in an FDA agreed upon registration trial in combination with two other drugs, Herceptin® (Trastuzumab) and Taxol (Paclitaxel) vs. Herceptin® and Taxol alone, the current standard of care for first line HER-2-overexpressing metastatic breast cancer. Myocet™, a liposome-encapsulated doxorubicin with reduced cardiotoxicity, is a nanotechnology product that localizes into tumor vasculature and in contrast to parental doxorubicin avoids homing to the heart. This 363 patient global trial in twelve countries has as of 03/06/09 been fully recruited. Unblinding is anticipated by the summer of 2010 with NDA submission for full approval following within 6 months. Myocet® is already a registered drug in Canada, where Sopherion has commercial rights and in Europe where Cephalon has commercial rights for use in first line metastatic breast cancer in combination with cyclophosphamide.; Their Phase III trial is based on a Phase II trial, supported by Roche, which gave a 96% response rate and two and a half year median progression free survival for patients with metastatic breast cancer.

Atrenta

Series B in 2003
Atrenta’s SpyGlass Predictive Analysis software platform significantly improves design efficiency for the world’s leading semiconductor and consumer electronics companies. Patented solutions provide early design insight into the demanding performance, power and area requirements of the complex system on chips (SoCs) fueling today’s consumer electronics revolution. More than two hundred companies and thousands of design engineers worldwide rely on SpyGlass to reduce risk and cost before traditional EDA tools are deployed. SpyGlass functions like an interactive guidance system for design engineers and managers, finding the fastest and least expensive path to implementation for complex SoCs. SpyGlass from Atrenta: Insight. Efficiency. Confidence.

VIEO

Series B in 2003
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

Atrenta

Series C in 2004
Atrenta’s SpyGlass Predictive Analysis software platform significantly improves design efficiency for the world’s leading semiconductor and consumer electronics companies. Patented solutions provide early design insight into the demanding performance, power and area requirements of the complex system on chips (SoCs) fueling today’s consumer electronics revolution. More than two hundred companies and thousands of design engineers worldwide rely on SpyGlass to reduce risk and cost before traditional EDA tools are deployed. SpyGlass functions like an interactive guidance system for design engineers and managers, finding the fastest and least expensive path to implementation for complex SoCs. SpyGlass from Atrenta: Insight. Efficiency. Confidence.
CICLON Semiconductor Device Corporation (pronounced see-clone) is a leader in the design, development, and sale of high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions for high-performance information technology applications. The company was founded in 2004 and is based in Bethlehem, Pennsylvania. As of February 11, 2009, CICLON Semiconductor Device Corp. operates as a subsidiary of Texas Instruments Inc.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Ventaira Pharmaceuticals

Series C in 2005
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary electrohydrodynamic (EHD) aerosolization and formulation technologies.

Intellon Corporation

Series B in 2005
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.

Blaze Public Relations

Venture Round in 2005
The Blaze Company provides marketing communications services to travel, retail, entertainment, magazines, institutes, and financial services industries. The company offers press conference, media placement analysis, direct mail, event marketing, public relations, online research, and strategic corporate counsel. Its clientele includes Seagrams, Denis Austin, Cruise & Resort Magazine, Hollywood Marketing Corporation, Cafй Med, Tomy America Inc., and Glad Bags. The company is based in Venice, California. As of 05/12/2004, The Blaze Company is a subsidiary of Davies.

Traffic.com

Venture Round in 1999
Traffic.com believe that we are a leading provider of accurate, real-time traffic information in the United States, based on the quality of our traffic data and the extent of their geographic coverage. They offer detailed traffic information, including specific speeds, travel times and delay times.

Sonics

Series C in 2002
Sonics is a pioneer of network-on-chip (NoC) technology and today offers SoC designers the largest portfolio of intelligent, on-chip communications solutions for home entertainment, wireless, networking and mobile devices. With a broad array of silicon-proven IP, Sonics helps designers eliminate memory bottlenecks associated with complex, high-speed SoC design, streamline and unify data flows and solve persistent network challenges in embedded systems with multiple cores. As the leading supplier of on-chip communications networks for the embedded market, Sonics has enabled its customers to ship more than 750 million units worldwide. Founded in 1996, Sonics is headquartered in Milpitas, Calif. with offices worldwide.

Optichron

Series B in 2005
Optichron®, Inc., a leader in nonlinear signal processing technology, designs and manufactures integrated circuits that enable significant improvements in system-level cost:performance for communications applications. Founded in January 2003, Optichron focuses on a significant technology challenge - a solution to the performance bottleneck caused by nonlinear distortion, a long-standing engineering barrier in many industries relying on signal processing technologies. Industry experts have long recognized nonlinear distortion as the principal roadblock to tapping the optimum performance potential in communications, data conversion and other signal processing applications because previous engineering approaches were inefficient, inadequate, cumbersome or expensive. There team has developed a proprietary mathematical approach to solving nonlinear distortion, from which we have derived a robust integrated circuit architecture that is the core of our linearization products. By efficiently eliminating all types of nonlinear distortion, our linearization technology significantly improves the parameters for overall system design and, through reduced component count and more efficient operation, lowers cost and power consumption. We embed our linearization technology in our practical, high-performance linearization products for applications such as wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation.

iSpot.tv

Series A in 2013
Spot.tv provides marketers with real-time media measurement and performance insights to advertise and stay ahead of the competition. iSpot measurement and attribution analytics are used by every industry for decision making that drives sustainable growth. iSpot.tv attention analytics measures the propensity of consumers to interrupt an ad play on TV and iSpot conversion analytics is the new standard for TV attribution, directly connecting TV ad impressions with web, app, and other first-party data. The company was founded in 2012 and is headquartered in Bellevue, Washington.

Matrix

Series A in 2001
Provides services to measure Internet performance.

eRealty.com

Series E in 2003
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

Optichron

Venture Round in 2007
Optichron®, Inc., a leader in nonlinear signal processing technology, designs and manufactures integrated circuits that enable significant improvements in system-level cost:performance for communications applications. Founded in January 2003, Optichron focuses on a significant technology challenge - a solution to the performance bottleneck caused by nonlinear distortion, a long-standing engineering barrier in many industries relying on signal processing technologies. Industry experts have long recognized nonlinear distortion as the principal roadblock to tapping the optimum performance potential in communications, data conversion and other signal processing applications because previous engineering approaches were inefficient, inadequate, cumbersome or expensive. There team has developed a proprietary mathematical approach to solving nonlinear distortion, from which we have derived a robust integrated circuit architecture that is the core of our linearization products. By efficiently eliminating all types of nonlinear distortion, our linearization technology significantly improves the parameters for overall system design and, through reduced component count and more efficient operation, lowers cost and power consumption. We embed our linearization technology in our practical, high-performance linearization products for applications such as wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation.

Go-Active

Venture Round in 2000
Go-Active is a new online application service provider for the health club industry

BostInno

Seed Round in 2011
BostInno is a Boston-based online news portal that delivers news related to business, technology, education, and sports. It is operated by [Streetwise Media](http://www.crunchbase.com/organization/streetwise-media), a digital media and events company. Its editorial staff consists of fast, edgy, and opinionated members, and it is an open community publishing platform. BostInno was founded in 2001 and is based in Boston, M.A.

Netrake

Series C in 2002
Netrake Corporation provides voice and multimedia solutions across Internet protocol (IP) networks to wireline, wireless, cable, and fixed/mobile operators. The company offers session border controllers that enable connectivity, policies, and security for VoIP and video sessions when traversing IP-to-IP networks; security gateways to enable secure real-time sessions across Wi-Fi, broadband, and wireless networks in fixed mobile convergence deployments. Its products support carrier-to-carrier peering, residential/Internet service providers, and business VoIP access services. The company was founded in 2000 and is based in Plano, Texas. As of August 14, 2006, Netrake Corporation operates as a subsidiary of AudioCodes, Inc.

Skycross Inc.

Series E in 2011
[Skycross](http://www.skycross.com) is a global wireless antenna solutions company. They serve a range of market segments including handsets, data cards, USB dongles, laptops, access points, mobile personal entertainment devices, and more.

Celator Pharmaceuticals

Series B in 2005
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Circadiant Systems, Inc

Series B in 2001
Circadiant Systems, Inc. manufactures optical test systems for optical component developers, network equipment manufacturers, and telecom service providers. The company offers electrical/optical compliance system for module, host card and IC testing applications; HYDRA LRM-M that solves the issues of calibration, instrument drift, and system-to-system correlation that can normally slow product release; HYDRA MTS that solves the issues of calibration, instrument drift, and system-to-system correlation that normally slow design cycles; and optical standard tester-ST that accurately generates various optical impairments, including optical signal-to-noise ratio, as well as automates performance and conformance testing of 10 Gb/s devices and systems. It also provides OSS-RW that offers creation of different optical impairments for testing performance of 10 Gb/s devices; OST-SRS provides stressed receiver sensitivity conformance testing of 10 gigabit Ethernet devices; and A3318 that enables the OST to make stressed eye measurements. In addition, it offers long reach multimode solutions that offer a scant 100m coverage with conventional 850nm optics; protocol layer testing; electronic dispersion compensation testing; and system level testing solutions.

Moonshoot

Venture Round in 2010
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

VeriWave

Series C in 2006
Testing with VeriWave ensures maximum performance for mobile networks, devices and applications in the real world. From development through deployment and beyond, VeriWave helps leading manufacturers, service providers and users measure, analyze and improve speed, quality, interoperability, compliance and other pivotal aspects of mobile performance.

Zalicus

Series D in 2004
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

VeriWave

Series A in 2003
Testing with VeriWave ensures maximum performance for mobile networks, devices and applications in the real world. From development through deployment and beyond, VeriWave helps leading manufacturers, service providers and users measure, analyze and improve speed, quality, interoperability, compliance and other pivotal aspects of mobile performance.

Celarix

Private Equity Round in 2002
Celarix offers simply the best way to manage every aspect of your logistics operation. No longer do you have to piece together disparate information and fill in the gaps yourself. Whether you're a shipper or a transportation service provider, you owe it to yourself and your company to find out exactly what we have in store for you.

Pivotal Systems

Venture Round in 2012
Pivotal Systems Corporation designs, develops, manufactures, and sells gas flow controllers for the semiconductor industry in Asia and North America. The company's platform includes gas flow controller product lines that provide real-time monitoring and control of the critical parameters difficult to control in wafer processing. It serves integrated device manufacturers, foundries, and original equipment manufacturers. The company was founded in 2003 and is headquartered in Fremont, California.

Noble Biomaterials

Series B in 2012
Noble Biomaterials is a global leader in intelligent materials. Noble leverages world-class antimicrobial and conductive technologies to protect, save, heal, and improve lives. The company uses its proprietary silver bonding technology for mission-critical applications in the performance apparel, healthcare, industrial and emerging wearable technology markets. Its flagship brands, X-STATIC®, Ionic+™, DFENSE, and CIRCUITEX®, are used by hundreds of world-class licensees to provide odor elimination, infection prevention/management, biometric monitoring and conductive protection benefits. Its headquarters and manufacturing facilities are in Scranton, PA, and the company has offices in Europe, Asia and South America.

Apogee Photonics

Venture Round in 2005
As per the transaction announced on March 20, 2007, Apogee Photonics, Inc. was acquired by CyOptics, Inc. Apogee Photonics, Inc. engages in the design, development, and production integrated indium phosphide solutions for optical transmission systems that exceed the distance-extinction-power product for other optical semiconductor technologies. Its solutions include cooled, semi-cooled, and uncooled products for 10Gb/s and 40Gb/s transmission to several tier 1 system OEMs and module vendors. The company's products include thermistor-based temperature monitoring and modulator-based power monitoring products, electroabsorption-modulated lasers, and laser integrated modulators. Apogee Photonics, Inc. was formerly known as ASIP, Inc. Apogee Photonics, Inc. was founded in 2000 and is headquartered in Allentown, Pennsylvania with an additional office in New Jersey. The company also has sales locations in the United States, Canada, Europe, Israel, and Asia.

Netrake

Series D in 2004
Netrake Corporation provides voice and multimedia solutions across Internet protocol (IP) networks to wireline, wireless, cable, and fixed/mobile operators. The company offers session border controllers that enable connectivity, policies, and security for VoIP and video sessions when traversing IP-to-IP networks; security gateways to enable secure real-time sessions across Wi-Fi, broadband, and wireless networks in fixed mobile convergence deployments. Its products support carrier-to-carrier peering, residential/Internet service providers, and business VoIP access services. The company was founded in 2000 and is based in Plano, Texas. As of August 14, 2006, Netrake Corporation operates as a subsidiary of AudioCodes, Inc.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

T-Networks

Series C in 2005
Electronic Components, Modulators available from T-Networks Inc. based in Allentown, PA.

Net Effect Systems

Series C in 2007
NetEffect, Inc. operates as a network connectivity solutions company. The company develops and provides multi-gigabit Ethernet products. It offers iWARP Ethernet Channel Adapters, which simplify datacenter management by enabling a single, consolidated fabric for networking, storage, and clustering applications. The company's products implement IETF for Ethernet, while maintaining with existing Ethernet infrastructure in data center. It also provides data networking, cluster computing, and storage networking solutions. The company has strategic partnerships with ABAQUS; Blade.org; Ciara Technologies; Critical Software; Evergrid; Force10 Networks; Fujitsu Computer Products of America, Inc.; Fulcrum Microsystems; HP BladeSystem Solution Builder; Quadrics; VMware; and Woven Systems. The company was formerly known as Banderacom, Inc. and changed its name to NetEffect, Inc. in 2004. NetEffect, Inc. was founded in 1999 and is based in Austin, Texas. On August 27, 2008, NetEffect Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. As of October 14, 2008, NetEffect, Inc. operates as a subsidiary of Intel Corporation.

AirWalk Communications

Series B in 2011
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

Kleer

Series B in 2008
Kleer's unique wireless audio technology enables consumer electronic companies—such as Sennheiser, RCA, DigiFi, Cy-Fi, and Sleek Audio—to manufacture high-quality products. Kleer's fabless semiconductor wireless technology is ideal for OEMs of portable audio players, iPod and other MP3 accessories, home stereo/theater systems, earphones, headphones, and speakers. Kleer is currently working with 25 OEM partners on over 30 products, and distributes its products via direct sales in North America and distribution channels in Korea and Japan.

BroadCloud Communications

Series A in 2000
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.

CombinatoRx

Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.

Utility Associates

Series A in 1999
Utility Associates, Inc. offers mobile resource management solutions to command and control field operations. It offers AVaiL, which delivers a mobile operations command and control service that provides a view of the current location and status of mobile resources layered with data from various business systems, such as GIS, customer, and outage management yielding unparalleled awareness of mobile operations; AVaiL-Navigator, which provides an on board navigation system; AVaiL Tablet, which delivers various levels of mobile computing functionalities; AVaiL RFID, which delivers information on the location and status of various mobile resources; AVaiL Diagnostics, which delivers vehicle diagnostic information to AVaiL command and control; AVaiL Cell, which is downloaded to cell-phones; PadWORKS, a work management system for the utility industry; AVaiL Boost, which maintains wireless connectivity in geographic areas; and OnComm Rocket, which enables enterprises to track the location and status of various mobile assets, such as toolboxes, backhoes, personnel, and vehicles.

Powered

Series B in 2000
Powered is a social marketing consultancy that helps companies become more engaged in an increasingly digital, connected and social world. Utilizing a proven set of effective practices and technologies, Powered helps companies navigate the entire social marketing spectrum, providing social marketing: strategy, planning, program development and execution, program management, content marketing, blogger outreach, influencer activation, advocacy programs, branded communities, and branded events.

Immunicon

Series F in 2003
They are developing and commercializing proprietary cell-based research and diagnostic products with an initial focus on cancer. They believe that their current and future products can provide significant clinical benefits by giving physicians better information to understand, diagnose, treat and monitor cancer. They design their products to provide physicians and scientists with clinically meaningful information earlier than current diagnostic methods. Their technologies, which they brand as CellTracks, can identify, count and characterize the presence and quantity of a small number of tumor cells present in a blood sample. Their collaborator, Veridex, LLC, or Veridex, a Johnson & Johnson company, submitted a pre-market notification, or 510(k), to the US Food and Drug Administration, or FDA, in May 2003 for use of the CellSearch Epithelial Cell Kit in the management of metastatic breast cancer. They expect that the CellSearch Epithelial Cell Kit will be the initial product launched by Veridex based on their technologies. They believe that their products and underlying technology platforms have other applications in cancer diagnostics, in the development of cancer drugs and in cancer research. In addition, they believe that their proprietary technologies may have applications in other fields of medicine, such as cardiovascular and infectious diseases.

Skycross Inc.

Series C in 2006
[Skycross](http://www.skycross.com) is a global wireless antenna solutions company. They serve a range of market segments including handsets, data cards, USB dongles, laptops, access points, mobile personal entertainment devices, and more.

VIEO

Series A in 2001
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

Zalicus

Series E in 2005
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

WebVision

Series C in 2000
Webvisions provided shared hosting, dedicated server and co-location services to small and midsized businesses throughout Asia.

Sopherion Therapeutics

Series B in 2004
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company headquartered in Princeton, New Jersey with offices in Cheshire, Connecticut, Estero, Florida and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada. Sopherion’s current business focus is the execution of a Phase III, global, randomized, registration trial for first line therapy of invasive, metastatic breast cancer and the development and commercialization of Sopherion’s lead agent, Myocet™. Myocet is being investigated in an FDA agreed upon registration trial in combination with two other drugs, Herceptin® (Trastuzumab) and Taxol (Paclitaxel) vs. Herceptin® and Taxol alone, the current standard of care for first line HER-2-overexpressing metastatic breast cancer. Myocet™, a liposome-encapsulated doxorubicin with reduced cardiotoxicity, is a nanotechnology product that localizes into tumor vasculature and in contrast to parental doxorubicin avoids homing to the heart. This 363 patient global trial in twelve countries has as of 03/06/09 been fully recruited. Unblinding is anticipated by the summer of 2010 with NDA submission for full approval following within 6 months. Myocet® is already a registered drug in Canada, where Sopherion has commercial rights and in Europe where Cephalon has commercial rights for use in first line metastatic breast cancer in combination with cyclophosphamide.; Their Phase III trial is based on a Phase II trial, supported by Roche, which gave a 96% response rate and two and a half year median progression free survival for patients with metastatic breast cancer.

eRealty.com

Venture Round in 2000
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

AirWalk Communications

Series B in 2008
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

Highway To Health

Venture Round in 2000
Highway to Health, Inc. (HTH) applies its dynamic Internet expertise to bring innovative online healthcare services and insurance to international travel, study and commerce. Each year thousands of leisure and business travelers as well as international students and scholars protect themselves, their families and their travel plans with HTH. Their programs combine comprehensive, competitively priced insurance products with critical travel health information, known as CityHealthProfiles, and online medical assistance services available through HTH TravelersClub. Members enjoy access to their community of pre-selected, contracted physicians in over 100 countries, and their interactive translation guides for brand name pharmaceuticals and common medical terms and phrases.

Isochron Data

Series A in 2000
Isochron Data Corporation (Isochron) is the leading application service provider of enterprise information solutions and wireless devices for customers seeking to communicate with their distributed field assets. Isochron's solutions connect people, devices, and enterprise systems to provide customers with vital information to improve their top and bottom lines. With Isochron's solutions, managers have direct control over their field assets and immediate access to timely, accurate, and actionable information to better manage their businesses.

Ikanos

Series E in 2004
Ikanos develops robust, high performance semiconductor and software products. Their advanced communications processors, broadband DSL and other devices power access infrastructure and customer premises equipment for many of the world’s leading network equipment manufacturers and telecommunications service providers. With more than 330 million ports shipped to date, they are enabling the cost-effective delivery of triple- and quadruple-play services to and throughout homes and offices around the world.

Atrenta

Venture Round in 2006
Atrenta’s SpyGlass Predictive Analysis software platform significantly improves design efficiency for the world’s leading semiconductor and consumer electronics companies. Patented solutions provide early design insight into the demanding performance, power and area requirements of the complex system on chips (SoCs) fueling today’s consumer electronics revolution. More than two hundred companies and thousands of design engineers worldwide rely on SpyGlass to reduce risk and cost before traditional EDA tools are deployed. SpyGlass functions like an interactive guidance system for design engineers and managers, finding the fastest and least expensive path to implementation for complex SoCs. SpyGlass from Atrenta: Insight. Efficiency. Confidence.

Planalytics, Inc.

Venture Round in 2001
Planalytics, Inc. provides business weather intelligence to actionable information companies to understand and optimize the impact of weather throughout all facets of an organization. The company provides insights to understand and quantify the impact of weather volatility on top-level transactions by time period and location. Its weather-driven demand analytics, online tools, reports, and services empower businesses to manage weather’s impact. The company serves customers in Europe, Mexico, and Latin America. Planalytics, Inc. was formerly known as Strategic Weather Services, Inc. and changed its name to Planalytics, Inc. in April 2000. The company was founded in 1996 and is based in Berwyn, Pennsylvania.

AirWalk Communications

Series B in 2006
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

Sabeus Photonics

Series C in 2001
Sabeus Photonics optical devices and expand manufacturing facilities. Sabeus supplies optical communications components.

Ikanos

Series D in 2003
Ikanos develops robust, high performance semiconductor and software products. Their advanced communications processors, broadband DSL and other devices power access infrastructure and customer premises equipment for many of the world’s leading network equipment manufacturers and telecommunications service providers. With more than 330 million ports shipped to date, they are enabling the cost-effective delivery of triple- and quadruple-play services to and throughout homes and offices around the world.

Moonshoot

Venture Round in 2012
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.

BroadCloud Communications

Series B in 2002
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.

CorrectNet

Series B in 2004
CorrectNet is the market leader in managed service-based information delivery and client reporting for many of the world's largest investment management firms. Founded in 1997, CorrectNet provides infrastructure, operations and people to manage the aggregation, enrichment, quality assurance and formatting of complex investment data, delivered through rich reporting web portals to investors, portfolio managers, operations teams and executives. CorrectNet has demonstrated a unique ability to satisfy the toughest transparency and reporting standards of leading hedge funds, funds of funds, fund administrators and prime brokers.
Translarity is an innovator in the semiconductor wafer test industry, focused on the advanced probe card market. Headquartered in Silicon Valley, Translarity brings a disruptive change to the world of semiconductor test by offering a full-wafer test with low cost, high performance, and short cycle time. Translarity acquired BucklingBeam in 2017 to expand its offerings and deliver a full suite of probe card solutions, including full probe cards and vertical probe head solutions. Combined with the company’s advanced Space Translator™ space transformer technology, the company addresses the rapid state of acceleration in probe technologies. Translarity’s proven management team, backed by strong financial investors, recruited a dynamic team of top industry talent to address the unmet challenges in building the Wafer Translator™ technology. In creating the Translarity solution, the team developed a fertile innovation pipeline and a strong IP portfolio, with more than 45 patents already issued and more than 50 filed.

Donuts

Series C in 2015
Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.

ScaleMP

Series D in 2008
ScaleMPâ„¢ is the leader in virtualization for high-end computing, providing higher performance and lower Total Cost of Ownership (TCO). The innovative Versatile SMPâ„¢ (vSMP) architecture aggregates multiple x86 systems into a single virtual x86 system, delivering an industry-standard, high-end symmetric multiprocessor (SMP) computer. Using software to replace custom hardware and components, ScaleMP offers a new, revolutionary computing paradigm.

Ineto

Series B in 2000
Ineto operates as a new customer communications service provider.
Translarity is an innovator in the semiconductor wafer test industry, focused on the advanced probe card market. Headquartered in Silicon Valley, Translarity brings a disruptive change to the world of semiconductor test by offering a full-wafer test with low cost, high performance, and short cycle time. Translarity acquired BucklingBeam in 2017 to expand its offerings and deliver a full suite of probe card solutions, including full probe cards and vertical probe head solutions. Combined with the company’s advanced Space Translator™ space transformer technology, the company addresses the rapid state of acceleration in probe technologies. Translarity’s proven management team, backed by strong financial investors, recruited a dynamic team of top industry talent to address the unmet challenges in building the Wafer Translator™ technology. In creating the Translarity solution, the team developed a fertile innovation pipeline and a strong IP portfolio, with more than 45 patents already issued and more than 50 filed.

Coriolis Networks

Series C in 2001
Coriolis Networks, headquartered in Boxborough, Mass., began in mid 1999 with a mission to develop a comprehensive approach to the needs of carriers for reliable and scalable optical network solutions. From the beginning, Coriolis Networks realized that success in this market would be based on providing customers with a solution that was compatible with existing SONET network architectures but dramatically improved on the data service delivery capability with new lower price points. Coriolis' target market is the network service provider community on a global basis. Our target customers include competitive and incumbent local exchange carriers, Internet service providers, and wholesale carriers that are building out their fiber-optic facilities to meet their end-user demands for more high-speed data services as well as traditional metro services.

Celarix

Series C in 2000
Celarix offers simply the best way to manage every aspect of your logistics operation. No longer do you have to piece together disparate information and fill in the gaps yourself. Whether you're a shipper or a transportation service provider, you owe it to yourself and your company to find out exactly what we have in store for you.

Sonics

Series C in 2004
Sonics is a pioneer of network-on-chip (NoC) technology and today offers SoC designers the largest portfolio of intelligent, on-chip communications solutions for home entertainment, wireless, networking and mobile devices. With a broad array of silicon-proven IP, Sonics helps designers eliminate memory bottlenecks associated with complex, high-speed SoC design, streamline and unify data flows and solve persistent network challenges in embedded systems with multiple cores. As the leading supplier of on-chip communications networks for the embedded market, Sonics has enabled its customers to ship more than 750 million units worldwide. Founded in 1996, Sonics is headquartered in Milpitas, Calif. with offices worldwide.

Celator Pharmaceuticals

Series C in 2007
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Finite Carbon

Series A in 2009
Finite Carbon Corporation provides forest carbon development and commercialization services in the United States. It offers a carbon-market solution that gives forest landowners immediate access to carbon markets. The company also offers resources and capital to implement forest carbon inventories, pre-assessment carbon modeling, protocol selection, project design, verification management, and marketing and selling of carbon credits. It helps landowners, public agencies, land trusts, and consulting foresters to measure, register, monitor, and monetize their carbon credits. The company was incorporated in 2009 and is based in Wayne, Pennsylvania. As of December 16, 2020, Finite Carbon Corporation operates as a subsidiary of BP p.l.c.

IPnetwork

Series B in 2000
IPnetwork provides foreign advertising solutions via TV, radio, and internet delivery platforms.

B-there.com

Venture Round in 2001
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.

B-there.com

Venture Round in 2000
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.

AirWalk Communications

Series A in 2003
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

eRealty.com

Series B in 2001
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

VeriWave

Series B in 2005
Testing with VeriWave ensures maximum performance for mobile networks, devices and applications in the real world. From development through deployment and beyond, VeriWave helps leading manufacturers, service providers and users measure, analyze and improve speed, quality, interoperability, compliance and other pivotal aspects of mobile performance.

Circles

Series B in 2000
Circles is an innovative personal services provider that reliably completes simple, complex and unique tasks by integrating leading edge technology and proprietary knowledge with high touch assistance. Founded in 1997 by Kathy Sherbrooke and Janet Kraus, graduates of Stanford Business School, Circles revolutionizes how corporations build life-long relationships with their employees and customers by offering end-user members comprehensive and simplified personal assistance for doing anything from completing household chores to events planning to tracking down the hard-to-find. Circles' clients are progressive organizations that have partnered with Circles to attract, retain and build loyalty with customers and employees.

Hire.com

Venture Round in 2000
The online marketplace for outdoor activities. Providing the consumer with a single platform to research, book, and review outfitters and guides. GuideHire creates an informed buyer in a centralized marketplace.

Zalicus

Series C in 2002
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

ClariFI

Venture Round in 2006
ClariFI, Inc. provides software and services focusing on quantitative investment management and research. It offers ModelStation, a solution with data management, factor backtesting, model construction, strategy simulation, portfolio optimization, risk and performance attribution, production scheduling, and enterprise adoption modules. The company's services include data integration and management, workflow creation, statistical/computational algorithms, risk model development, forecast model development, and strategy script development. It also provides integration services to in-house data warehouses or custom feeds. The company was founded in 1999 and is headquartered in New York, New York with additional offices in Boston, Massachusetts; El Segundo, California; and London, United Kingdom. As of May 15, 2007, ClariFI, Inc. operates as a subsidiary of Capital IQ, Inc.

NorthStar Systems International

Venture Round in 2007
NorthStar Systems International, Inc. provides wealth management software solutions to financial services institutions primarily in the United States. Its solutions include NorthStar Client Acquisition Solution that allows asset managers and wealth management firms to provide their advisors the client profiling and communication tools; NorthStar Client Reporting Solution, which enables wealth managers to offer reports and reviews for clients; NorthStar Compliance Solution that offers compliance systems' functionalities; and NorthStar Product Catalog Solution, which allows wealth managers to build customized portfolios. The company also offers client hierarchy, enterprise product hub, planning and portfolio construction, data, and platform services; and professional and technical support services. Its solutions allow users to automate and streamline their wealth management workflows. The company serves financial advisors, wealth managers, banks, trusts, broker-dealers, multi-family offices, and service providers. It delivers its solutions on-premise or on-demand. The company was founded in 2001 and is based in San Francisco, California.

Donuts

Series A in 2012
Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.

Intellon Corporation

Venture Round in 2004
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.

Factory Logic

Series A in 2000
Factory Logic, Inc. provides factory management solutions. The company develops Streamline Lean Factory Management System, an operational management software solution that provides factory personnel with the integrated tools to design, operate, and improve lean manufacturing facilities. Its Lean Operations suite supports an integrated approach that directly links production to customer demand, as well as maintains stability required for factory and supply chain operations. The company also undertakes consulting projects. It serves automotive, electronics, industrial equipment, and aerospace industries. The company was formerly known as Scintellect Systems, Inc. The company was founded in 1993 and is based in Austin, Texas. As of December 18, 2006, Factory Logic, Inc. operates as a subsidiary of SAP AG.

Sonics

Series D in 2005
Sonics is a pioneer of network-on-chip (NoC) technology and today offers SoC designers the largest portfolio of intelligent, on-chip communications solutions for home entertainment, wireless, networking and mobile devices. With a broad array of silicon-proven IP, Sonics helps designers eliminate memory bottlenecks associated with complex, high-speed SoC design, streamline and unify data flows and solve persistent network challenges in embedded systems with multiple cores. As the leading supplier of on-chip communications networks for the embedded market, Sonics has enabled its customers to ship more than 750 million units worldwide. Founded in 1996, Sonics is headquartered in Milpitas, Calif. with offices worldwide.

JAM Technologies

Series B in 2006
JAM Technologies operates as a mixed signal semiconductor company. It designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. JamTech offers True Fidelity sub-ranging pulse width modulation digital amplifiers. It sells its ICs through direct sales force and distributors. The company was founded in 1999 and is headquartered in Austin, Texas, with an additional office in Singapore.

AirWalk Communications

Venture Round in 2003
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.

iMedium

Series B in 2000
IMedium, Inc. develops an Application Service Provider (ASP) that enables the delivery of highly visual, intuitive Web interactions to business customers, future clients and trading partners.

BayPackets

Series C in 2003
BayPackets' software enables wireless, wireline and cable operators to rapidly bundle and deliver enhanced voice and data services tailored to the needs of their business and consumer customers. Local, long-distance and broadband service providers rely on BayPackets' solutions to profitably expand their market share by efficiently operating new and existing network infrastructure via a single point.

AirWalk Communications

Series A in 2004
AirWalk Communications offers a complete line of IP-based Radio Access Network (IP-RAN) solutions that enable simple network expansion for CDMA wireless service providers. AirWalk’s solution is based on a distinctive approach, the controller functionality is decentralized and tightly integrated with a base station transceiver in one compact device. This approach reduces equipment complexity and latency, and for service providers this translates to increased reliability, simpler installation, lower costs, and a smaller system footprint.